SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVTX - CV Therapeutics, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (115)11/10/2003 10:31:31 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 411
 
>> "We are very pleased with the results of our Phase II trial of oral ADENTRI and plan to meet with the FDA to review these data in preparation for moving forward with the development of this promising compound" <<

Last I heard, Biogen was trying to out-license the sucker. Is this enthusiasm a new plus for the CVTX business plan?